- Imatinib mesylate in the palliative treatment of patients with advanced gastrointestinal stromal tumor2012 | Publication without faculty affiliation
- Impact of age on the clinical response of patients with CML treated with imatinib2015 | Faculty of Medicine in Hradec Králové
- Persistent splenomegaly during imatinib therapy and the definition of complete hematological response in chronic myelogenous leukemia2010 | Faculty of Medicine in Hradec Králové
- BCR-ABL mutation analysis allows to provide "tailors therapy" for CML patients resistant to imatinib2010 | Faculty of Medicine in Hradec Králové
- Intestinal permeability, vitamin A absorption and serum alpha-tocopherol in gastrointestinal stromal tumor patients treated with imatinib2010 | Faculty of Medicine in Hradec Králové, Faculty of Pharmacy in Hradec Králové
- Combination of imatinib and anagrelide in treatment of chronic myeloid leukemia in blastic phase2006 | First Faculty of Medicine
- Pathological complete response in advanced gastrointestinal stromal tumor after imatinib therapy2005 | First Faculty of Medicine, Faculty of Medicine in Pilsen
- Imatinib in the first-line treatment of chronic myelogenous leukemia in chronic phase2008 | First Faculty of Medicine
- Imatinib in the first-line treatment of chronic myelogenous leukemia in chronic phase2008 | Publication without faculty affiliation
- Imatinib mesylate (Glivec) in treatment of chronic myeloid leukemia in chronic phase2004 | Faculty of Medicine in Hradec Králové, Central Library of Charles University
- Imatinib (glivec) in the Treatment of patients with CML in accelerated phase and Ph+ ALL2003 | First Faculty of Medicine
- Imatinib - The New Perspective in the Anticancer Therapy2004 | First Faculty of Medicine
- Pathological Complete Response in Advanced Gastrointestinal Stromal Tumor after Imatinib Therapy2005 | Publication without faculty affiliation
- Pathological Complete Response in Advanced Gastrointestinal Stromal Tumor after Imatinib Therapy2005 | First Faculty of Medicine
- Imatinib resistance in CML treatment +12008 | Publication without faculty affiliation
- Resistance to imatinib and the possibilities of use of the dose escalation of the drug in patients with chronic myeloid leukemia2007 | First Faculty of Medicine
- Imatinib mesylate efficacy in 72 previously treated Philadelphia-positive chronic myeloid leukemia patients with and without additional chromosomal changes: single-center results2009 | Publication without faculty affiliation
- Fatal venous thrombembolism complicating imatinib therapy in patient with metastatic gastrointestinal stromal tumor2006 | Publication without faculty affiliation
- Fatal venous thrombembolism complicating imatinib therapy in patient with metastatic gastrointestinal stromal tumor2006 | Faculty of Medicine in Hradec Králové
- Fatal venous thrombembolism complicating imatinib therapy in patient with metastatic gastrointestinal stromal tumor2006 | First Faculty of Medicine
- Pathological Complete Response in Advanced Gastrointestinal Stromal Tumor after Imatinib Therapy2005 | Faculty of Medicine in Hradec Králové
- Research Report University Hospital for clinical assessment CA180399Publication without faculty affiliation
- Dasatinib in imatinib-resistant or -intolerant CML patients: data from the clinical practice of 6 hematological centers in the Czech Republic2010 | Faculty of Physical Education and Sport, Faculty of Medicine in Hradec Králové
- Dasatinib in imatinib-resistant or -intolerant CML patients: data from the clinical practice of 6 hematological centers in the Czech Republic2010 | First Faculty of Medicine
- Final report of University Hospital Hradec Kralove to the clinical trial protocol no. AV001Publication without faculty affiliation
- Treatment of gastrointestinal stromal tumours2010 | Second Faculty of Medicine
- Imatinib (glivec) in the Treatment of patients with CML in accelerated phase and Ph+ ALL2003 | Faculty of Medicine in Hradec Králové
- Combination of imatinib and anagrelide in treatment of chronic myeloid leukemia in blastic phase2006 | Faculty of Medicine in Hradec Králové
- Gastrointestinal stromal tumour: advances in treatment2020 | Publication without faculty affiliation